A patient with stage IIIB advanced breast cancer who is still alive 24 years after surgery: a case report and remarks on the treatment strategies

BACKGROUND: In recent years, a number of agents possessing novel mechanisms, such as cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors and PIK3CA inhibitors, have been developed for the treatment of hormone receptor-positive (HR+) human epidermal growth factor receptor type negative (HER2−) advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoneto, Toshihiko, Hasumi, Kenichiro, Fujii, Yuzo, Takahashi, Nobukazu, Seki, Natsuki, Yoshimoto, Takayuki, Takeda, Yasutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641138/
https://www.ncbi.nlm.nih.gov/pubmed/36388043
http://dx.doi.org/10.21037/tcr-22-1363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641138/
https://www.ncbi.nlm.nih.gov/pubmed/36388043
http://dx.doi.org/10.21037/tcr-22-1363

Ejemplares similares